Management tracks

Cell therapy play BlueRock Therapeutics (Toronto, Ontario) named Emile Nuwaysir president and CEO, and Robert Deans chief technology officer. Nuwaysir was president and COO at Cellular Dynamics International Inc., which Fujifilm Holdings Corp. (Tokyo:4901) acquired in 2015. Deans was CSO at Rubius Therapeutics Inc. (Cambridge, Mass.).


Read the full 468 word article

How to gain access

Continue reading with a
two-week free trial.